Jason Michael Gehrke

This inventor holds 12 USPTO granted patents and 20 published patent applications and 2 EPO patents. Top assignees: Beam Therapeutics Inc., The General Hospital Corporation, Ucl Business Plc. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason Michael Gehrke. Retrieved from https://idiyas.com/inventor/jason-michael-gehrke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 20)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 26)

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 10(Granted Patents)

Location History:

Santa Barbara, CA (US) (2021)
Cambridge, MA (US) (2021 - 2023)

Company Filing History:

7 out of 19

Beam Therapeutics Inc.

patents

5 out of 3,071

The General Hospital Corporation

where one patent can have more than one assignee

Years Active: 2021-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12612618 - Nucleobase editors having reduced non-target deamination and assays for characterizing nucleobase editors (2026-04-28),

2. 12601009 - HIGHLY SENSITIVE IN VITRO ASSAYS TO DEFINE SUBSTRATE PREFERENCES AND SITES OF NUCLEIC-ACID BINDING, MODIFYING, AND CLEAVING AGENTS (2026-04-14),

3. 12600971 - Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence (2026-04-14),

4. 12594301 - Compositions and methods for treatment of liquid cancers (2026-04-07),

5. 12576151 - Fratricide resistant modified immune cells and methods of using the same (2026-03-17),

6. 12454694 - Compositions and methods for improving base editing (2025-10-28),

7. 12286641 - Methods for increasing efficiency of nuclease-induced homology-directed repair (2025-04-29),

8. 12133884 - Methods of substituting pathogenic amino acids using programmable base editor systems (2024-11-05),

9. 11725228 - Methods for detecting site-specific and spurious genomic deamination induced by base editing technologies (2023-08-15),

10. 11326157 - Base editors with improved precision and specificity (2022-05-10),

11. 11155803 - Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence (2021-10-26),

12. 11021718 - Methods for increasing efficiency of nuclease-induced homology-directed repair (2021-06-01),

Title: The Innovative Journey of Jason Michael Gehrke

Introduction: Jason Michael Gehrke is a pioneering inventor based in Cambridge, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jason Michael Gehrke holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Jason Michael Gehrke has successfully brought numerous inventions from concept to reality, revolutionizing industries along the way.

Collaborations: Throughout his career, Jason Michael Gehrke has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his innovative ideas, solidifying his reputation as a visionary inventor.

Conclusion: Jason Michael Gehrke's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true trailblazer in the world of inventions. His impact on various sectors is profound, and his legacy as an inventor continues to inspire future generations of innovators.

Profile summary based on public USPTO records.